NextGen Healthcare, Inc. (NXGN): Price and Financial Metrics


NextGen Healthcare, Inc. (NXGN): $16.22

-0.07 (-0.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NXGN POWR Grades


  • Stability is the dimension where NXGN ranks best; there it ranks ahead of 84.2% of US stocks.
  • The strongest trend for NXGN is in Growth, which has been heading down over the past 31 weeks.
  • NXGN ranks lowest in Sentiment; there it ranks in the 28th percentile.

NXGN Stock Summary

  • NXGN's current price/earnings ratio is 114.62, which is higher than 92.87% of US stocks with positive earnings.
  • For NXGN, its debt to operating expenses ratio is greater than that reported by just 13.5% of US equities we're observing.
  • With a year-over-year growth in debt of -82.52%, Nextgen Healthcare Inc's debt growth rate surpasses merely 2.81% of about US stocks.
  • Stocks that are quantitatively similar to NXGN, based on their financial statements, market capitalization, and price volatility, are NTCT, OFLX, BCOV, ROG, and SRDX.
  • Visit NXGN's SEC page to see the company's official filings. To visit the company's web site, go to www.nextgen.com.

NXGN Valuation Summary

  • In comparison to the median Technology stock, NXGN's price/sales ratio is 64.15% lower, now standing at 1.9.
  • Over the past 243 months, NXGN's EV/EBIT ratio has gone up 68.3.
  • NXGN's EV/EBIT ratio has moved up 68.3 over the prior 243 months.

Below are key valuation metrics over time for NXGN.

Stock Date P/S P/B P/E EV/EBIT
NXGN 2016-06-01 1.6 2.9 138.4 112.2
NXGN 2015-08-11 1.5 2.7 26.7 17.4
NXGN 2013-02-27 2.4 3.4 17.9 10.6
NXGN 2011-04-11 7.2 11.3 42.8 26.5
NXGN 2004-07-06 4.2 4.8 28.4 14.3
NXGN 2001-09-28 1.5 1.8 15.1 6.1

NXGN Growth Metrics

  • Its year over year revenue growth rate is now at 3.07%.
  • The 5 year cash and equivalents growth rate now stands at 36.72%.
  • Its 5 year price growth rate is now at -31.63%.
Over the past 49 months, NXGN's revenue has gone up $47,197,000.

The table below shows NXGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 556.821 98.518 9.515
2020-12-31 549.015 97.208 5.853
2020-09-30 545.003 92.869 9.804
2020-06-30 539.257 86.276 5.43
2020-03-31 540.239 85.601 7.498
2019-12-31 538.642 81.567 15.668

NXGN Price Target

For more insight on analysts targets of NXGN, see our NXGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $21.25 Average Broker Recommendation 1.85 (Hold)

NXGN Stock Price Chart Interactive Chart >

Price chart for NXGN

NXGN Price/Volume Stats

Current price $16.22 52-week high $23.80
Prev. close $16.29 52-week low $11.80
Day low $15.10 Volume 362,600
Day high $16.46 Avg. volume 353,428
50-day MA $16.86 Dividend yield N/A
200-day MA $17.86 Market Cap 1.09B

NextGen Healthcare, Inc. (NXGN) Company Bio


NextGen Healthcare (formerly Quality Systems) develops and markets computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. The company was founded in 1974 and is based in Irvine, California.

NXGN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$16.22$10.22 -44%

We started the process of determining a valid price forecast for Nextgen Healthcare Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Nextgen Healthcare Inc ranked in the 39th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Nextgen Healthcare Inc ended up being:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 95. Notably, its equity weight is greater than 63.74% of US equities in the Technology sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than just 18.85% of the free cash flow producing stocks we're observing.
  • Nextgen Healthcare Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-45%
1%-45%
2%-44%
3%-44%
4%-43%
5%-43%

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as NXGN, try PERI, ESE, FTV, QCOM, and SSNT.


NXGN Latest News Stream


Event/Time News Detail
Loading, please wait...

NXGN Latest Social Stream


Loading social stream, please wait...

View Full NXGN Social Stream

Latest NXGN News From Around the Web

Below are the latest news stories about Nextgen Healthcare Inc that investors may wish to consider to help them evaluate NXGN as an investment opportunity.

NextGen Healthcare Fully Prevails in Hussein Trial Jury Verdict

ATLANTA, July 30, 2021--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, announced that the Ahmed D. Hussein v. Sheldon Razin, Steven Plochocki and Quality Systems, Inc. lawsuit filed in the Superior Court of the State of California for the County of Orange on October 7, 2013 concluded on July 29, 2021 with a jury verdict in favor of the Company and Messrs. Razin and Plochocki on all counts with no financial liability for the Company. As suc

Yahoo | July 30, 2021

NextGen Healthcare (NXGN) Q1 Earnings & Revenues Top Estimates

NextGen Healthcare's (NXGN) fiscal first-quarter earnings reflect strong segmental performance.

Yahoo | July 30, 2021

NextGen Healthcare, inc (NXGN) Q1 2022 Earnings Call Transcript

Image source: The Motley Fool. NextGen Healthcare, inc (NASDAQ: NXGN)Q1 2022 Earnings CallJul 29, 2021, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to the NextGen Healthcare Fiscal 2022 First Quarter Financial Results Conference Call.

Yahoo | July 30, 2021

Nextgen Healthcare (NXGN) Surpasses Q1 Earnings and Revenue Estimates

Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 19.05% and 4.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 29, 2021

NextGen Healthcare Reports Fiscal 2022 First Quarter Results

ATLANTA, July 29, 2021--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal first quarter ended June 30, 2021.

Yahoo | July 29, 2021

Read More 'NXGN' Stories Here

NXGN Price Returns

1-mo -1.82%
3-mo -13.86%
6-mo -17.41%
1-year 10.94%
3-year -22.80%
5-year 35.28%
YTD -11.07%
2020 13.50%
2019 6.07%
2018 11.56%
2017 3.27%
2016 -18.42%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8656 seconds.